Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

Aaron J Tande; Melanie D Swift; Douglas W Challener; Elie F Berbari; Christopher P Tommaso; Darrin R Christopherson; Matthew J Binnicker; Laura E Breeher

doi:10.1093/cid/ciac235

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

Clin Infect Dis. 2022 Aug 24;75(1):e347-e349. doi: 10.1093/cid/ciac235.

Authors

Aaron J Tande¹, Melanie D Swift^{1

2}, Douglas W Challener¹, Elie F Berbari¹, Christopher P Tommaso², Darrin R Christopherson¹, Matthew J Binnicker³, Laura E Breeher^{1

2}

Affiliations

¹ Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Occupational Health Services, Mayo Clinic, Rochester, Minnesota, USA.
³ Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

We report the utility of rapid antigen tests (RAgT) in a cohort of US healthcare personnel with coronavirus disease 2019 (COVID-19) infection who met symptom criteria to return to work at day 5 or later of isolation. In total, 11.9% of initial RAgT were negative. RAgT can be helpful to guide return to work decisions.

Keywords: COVID-19; SARS-CoV-2.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19* / diagnosis
Delivery of Health Care
Follow-Up Studies
Health Personnel
Humans
SARS-CoV-2*